Stage 2 cervical cancer is classified into 2A and 2B, based on tumor spread and size, affecting treatment decisions. Diagnosis involves biopsies and imaging tests, including CT, MRI, and PET scans, to ...
In May 2024, the Food and Drug Administration (FDA) approved two new cervical screening tests for detecting human papillomavirus (HPV), which causes almost all cervical cancers. Both allow individuals ...
In 2023, cervical cancer screening rates still remained below prepandemic levels, new survey data suggested. However, screening rates for breast and colorectal cancers rebounded from pandemic declines ...
MRI identified missed cervical spine injuries in 17% of patients with trauma who had negative CT results, prompting treatment changes in 4% of them. MRI identified missed injuries in 17% of patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results